Rheumatic disease and artistic creativity

por Chatzidionysiou, Katerina
Publicado 2019

Mediterranean Journal of Rheumatology March 2020 Highlights

por Chatzidionysiou, Katerina
Publicado 2020

Beyond Methotrexate and Biologics in RA – Efficacy of JAK Inhibitors and their Place in the Current Treatment Armamentarium

por Chatzidionysiou, Katerina
Publicado 2020

The Rheumatologist’s Role in the Battle Against COVID-19: Insights from the Front Line and Challenges for the Future

por Koutsianas, Christos, Chatzidionysiou, Katerina
Publicado 2020

Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shift

por Chatzidionysiou, Katerina, Sfikakis, Petros P
Publicado 2019

Could severe COVID-19 be considered a complementopathy?

por Chatzidionysiou, Katerina, Svenungsson, Elisabet, Faustini, Francesca
Publicado 2020

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases

por Md Yusof, Md Yuzaiful, Alivernini, Stefano, Chatzidionysiou, Katerina
Publicado 2022

Intracardiac Thrombi in Morbus Adamantiades–Behçet in Two Swedish Patients

por Da Mutten, Raffaele, Borg, Alexander, Chatzidionysiou, Katerina, Parodis, Ioannis
Publicado 2023

Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?

por Chatzidionysiou, Katerina, Liapi, Matina, Tsakonas, Georgios, Gunnarsson, Iva, Catrina, Anca
Publicado 2020

Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking

por Chatzidionysiou, Katerina, di Giuseppe, Daniela, Soderling, Jonas, Catrina, Anca, Askling, Johan
Publicado 2022

Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus

por Parodis, Ioannis, Johansson, Petter, Gomez, Alvaro, Soukka, Sofia, Emamikia, Sharzad, Chatzidionysiou, Katerina
Publicado 2019

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort

por Györi, Noémi, Giannakou, Ioanna, Chatzidionysiou, Katerina, Magder, Laurence, van Vollenhoven, Ronald F, Petri, Michelle
Publicado 2017

Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort

por Giannakou, Ioanna, Chatzidionysiou, Katerina, Magder, Laurence S, Györi, Noemi, van Vollenhoven, Ronald, Petri, Michelle A
Publicado 2018

Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus

por Gomez, Alvaro, Soukka, Sofia, Johansson, Petter, Åkerström, Emil, Emamikia, Sharzad, Enman, Yvonne, Chatzidionysiou, Katerina, Parodis, Ioannis
Publicado 2020

Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL

por Chatzidionysiou, Katerina, Circiumaru, Alexandra, Rethi, Bence, Joshua, Vijay, Engstrom, Marianne, Hensvold, Aase, af Klint, Erik, Catrina, Anca
Publicado 2021

Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data

por Barbulescu, Andrei, Askling, Johan, Chatzidionysiou, Katerina, Forsblad-d’Elia, Helena, Kastbom, Alf, Lindström, Ulf, Turesson, Carl, Frisell, Thomas
Publicado 2022

Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic rev...

por Emamikia, Sharzad, Arkema, Elizabeth V, Györi, Noémi, Detert, Jacqueline, Chatzidionysiou, Katerina, Dougados, Maxime, Burmester, Gerd Rüdiger, van Vollenhoven, Ronald
Publicado 2016

Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden

por Di Giuseppe, Daniela, Lindstrom, Ulf, Bower, Hannah, Delcoigne, Bénédicte, Frisell, Thomas, Chatzidionysiou, Katerina, Sjöwall, Christopher, Lindqvist, Elisabet, Askling, Johan
Publicado 2021

Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy

por Ekberg, Neda Rajamand, Eliasson, Sofie, Li, Young Wen, Zheng, Xiaowei, Chatzidionysiou, Katerina, Falhammar, Henrik, Gu, Harvest F., Catrina, Sergiu-Bogdan
Publicado 2019

Corrigendum to “Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy”

por Ekberg, Neda Rajamand, Eliasson, Sofie, Li, Young Wen, Zheng, Xiaowei, Chatzidionysiou, Katerina, Falhammar, Henrik, Gu, Harvest F., Catrina, Sergiu-Bogdan
Publicado 2021